⌘K

Login Start Free

Home/Filings/4/0001209191-24-001151

4//SEC Filing

KIDRON NADAV 4

Accession 0001209191-24-001151

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:41 PM ET

Size

5.8 KB

Accession

0001209191-24-001151

Insider Transaction Report

Form 4

Period: 2024-01-04

ORAMED PHARMACEUTICALS INC.ORMP

DirectorPresident and CEO

Transactions

Award
Common Stock
2024-01-04+329,000→ 1,781,098 total

Holdings

Common Stock
(indirect: By wholly-owned corporation)
126,000

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 27,417 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001351779

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 4:41 PM ET
Size: 5.8 KB

View on SEC.gov